Effect of choroidal collateral vessels on de novo hemorrhage in moyamoya disease: analysis of nonhemorrhagic hemispheres in the Japan Adult Moyamoya Trial

Restricted access

OBJECTIVE

Following hemorrhagic stroke in moyamoya disease, de novo intracranial hemorrhage can occur in the previously unaffected nonhemorrhagic hemisphere. In the present analysis the authors intended to determine whether the presence in the nonhemorrhagic hemisphere of choroidal collateral vessels, which have been the focus of attention as a source of bleeding, affects the risk of de novo hemorrhage.

METHODS

The subject of focus of the present cohort study was the nonhemorrhagic hemispheres of adult patients with hemorrhagic moyamoya disease enrolled in the Japan Adult Moyamoya Trial and allocated to the nonsurgical arm. The variable of interest was the presence of choroidal collaterals (also termed choroidal anastomoses), identified with baseline angiography and represented by a connection (anastomosis) between the anterior or posterior choroidal arteries and the medullary arteries. The outcome measure was de novo hemorrhage during the 5-year follow-up period, assessed in all nonhemorrhagic hemispheres. The incidence of de novo hemorrhage in the collateral-positive and -negative groups was compared.

RESULTS

Choroidal collaterals were present in 15 of 36 (41.7%) nonhemorrhagic hemispheres analyzed. The overall annual risk of de novo hemorrhage was 2.0%. Three de novo hemorrhages occurred in the collateral-positive group, whereas no hemorrhage occurred in the collateral-negative group. The annual risk of de novo hemorrhage was significantly higher in the collateral-positive group than in the collateral-negative group (5.8% per year vs 0% per year; p = 0.017). All hemorrhage sites corresponded to the distribution of choroidal collaterals.

CONCLUSIONS

The present preliminary results suggest that the presence of choroidal collaterals affects the risk of de novo hemorrhage in the nonhemorrhagic hemisphere, subject to verification in larger studies. Further studies are needed to determine the optimal treatment strategy for nonhemorrhagic hemispheres and asymptomatic patients.

ABBREVIATIONS JAM = Japan Adult Moyamoya; PCA = posterior cerebral artery; TIA = transient ischemic attack.
Article Information

Contributor Notes

Correspondence Susumu Miyamoto: Kyoto University, Kyoto, Japan. miy@kuhp.kyoto-u.ac.jp.INCLUDE WHEN CITING Published online February 8, 2019; DOI: 10.3171/2018.10.JNS181139.Disclosures The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.
Headings
References
  • 1

    Cho WSChung YSKim JEJeon JPSon YJBang JS: The natural clinical course of hemodynamically stable adult moyamoya disease. J Neurosurg 122:82892015

    • Search Google Scholar
    • Export Citation
  • 2

    Fujimura MFunaki THoukin KTakahashi JCKuroda STomata Y: Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease: case-control study of the Japan Adult Moyamoya Trial. J Neurosurg [epub ahead of print May 4 2018. DOI: 10.3171/2017.11.JNS171990]

    • Search Google Scholar
    • Export Citation
  • 3

    Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 (Suppl 2):S238S2401997

    • Search Google Scholar
    • Export Citation
  • 4

    Funaki TTakahashi JCHoukin KKuroda STakeuchi SFujimura M: Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg 128:7777842018

    • Search Google Scholar
    • Export Citation
  • 5

    Funaki TTakahashi JCHoukin KKuroda STakeuchi SFujimura M: High rebleeding risk associated with choroidal collateral vessels in hemorrhagic moyamoya disease: analysis of a nonsurgical cohort in the Japan Adult Moyamoya Trial. J Neurosurg [epub ahead of print March 2 2018. DOI: 10.3171/2017.9.JNS17576]

    • Search Google Scholar
    • Export Citation
  • 6

    Han DHKwon OKByun BJChoi BYChoi CWChoi JU: A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). Acta Neurochir (Wien) 142:126312742000

    • Search Google Scholar
    • Export Citation
  • 7

    Irikura KMiyasaka YKurata ATanaka RFujii KYada K: A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 138:128212861996

    • Search Google Scholar
    • Export Citation
  • 8

    Kim KMKim JECho WSKang HSSon YJHan MH: Natural history and risk factor of recurrent hemorrhage in hemorrhagic adult moyamoya disease. Neurosurgery 81:2892962017

    • Search Google Scholar
    • Export Citation
  • 9

    Kobayashi ESaeki NOishi HHirai SYamaura A: Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 93:9769802000

    • Search Google Scholar
    • Export Citation
  • 10

    Kuroda SHashimoto NYoshimoto TIwasaki Y: Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicenter survey in Japan. Stroke 38:143014352007

    • Search Google Scholar
    • Export Citation
  • 11

    Liu PLiu AHHan CChen CLv XLLi DS: Difference in angiographic characteristics between hemorrhagic and nonhemorrhagic hemispheres associated with hemorrhage risk of moyamoya disease in adults: a self-controlled study. World Neurosurg 95:3483562016

    • Search Google Scholar
    • Export Citation
  • 12

    Miyamoto SYoshimoto THashimoto NOkada YTsuji ITominaga T: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke 45:141514212014

    • Search Google Scholar
    • Export Citation
  • 13

    Mohr JPParides MKStapf CMoquete EMoy CSOverbey JR: Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 383:6146212014

    • Search Google Scholar
    • Export Citation
  • 14

    Morioka MHamada JKawano TTodaka TYano SKai Y: Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke 34:90952003

    • Search Google Scholar
    • Export Citation
  • 15

    Morita AKirino THashi KAoki NFukuhara SHashimoto N: The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 366:247424822012

    • Search Google Scholar
    • Export Citation
  • 16

    Research Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis: Guidelines for diagnosis and treatment of moyamoya disease (spontaneous occlusion of the circle of Willis). Neurol Med Chir (Tokyo) 52:2452662012

    • Search Google Scholar
    • Export Citation
  • 17

    Suzuki JKodama N: Moyamoya disease—a review. Stroke 14:1041091983

TrendMD
Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 86 86 86
Full Text Views 40 40 40
PDF Downloads 63 63 63
EPUB Downloads 0 0 0
PubMed
Google Scholar